BMY FY 2018 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena

BMYBristol-Myers Squibb Company

$121B

FY 2018 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$22.6B+8.6% YoY

Gross Profit

$16.1B71.3% margin

Operating Income

$6.4B28.3% margin

Net Income

$4.9B21.8% margin

EPS (Diluted)

$3.03

Cash Flow

Operating Cash Flow

$7.1B

Free Cash Flow

$6.1B

Stock-Based Comp.

$221M

Balance Sheet

Total Assets

$35.0B

Total Liabilities

$20.9B

Stockholders' Equity

$14.0B

Cash & Equivalents

$6.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22.6B	$20.8B	+8.6%
Gross Profit	$16.1B	$15.0B	+7.5%
Operating Income	$6.4B	$5.2B	+22.0%
Net Income	$4.9B	$1.0B	+388.6%